Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115353511A details a mild Pd-catalyzed route for biheterocycles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent route for carbonyl-bridged biheterocycles, offering safer processing and cost reduction in API manufacturing.
Patent CN115286556B reveals green synthesis for indolinone esters. Discover cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
Patent CN115353511A details a mild, multi-component synthesis route for carbonyl-bridged biheterocycles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Patent CN115353511A details a safe, one-pot Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering cost reduction in API manufacturing.
Patent CN113735756A details a novel Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multi-component route for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable production.
Patent CN115353511A details a safe, multi-component synthesis of indolinone-imidazole derivatives using in-situ CO generation, offering significant cost reduction in API manufacturing.
Patent CN115286556B reveals a green Pd-catalyzed route for indolinone esters using dimethyl carbonate. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering cost-effective pharma intermediate manufacturing.
Patent CN115353511A details a safe, one-pot palladium-catalyzed method for synthesizing carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost and safety advantages.
Patent CN105237459B enables metal-free one-step synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer CO-surrogate protocols and enhanced supply chain reliability for API intermediates.
Patent CN115353511A details a safe Pd-catalyzed carbonylation route for indolinone-imidazole hybrids, offering reliable pharmaceutical intermediate supply.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.